Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barnes, E. A.
Right arrow Articles by Donoghue, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnes, E. A.
Right arrow Articles by Donoghue, D. J.
[Cancer Research 63, 3701-3707, July 1, 2003]
© 2003 American Association for Cancer Research


Molecular Biology and Genetics

Human Spy1 Promotes Survival of Mammalian Cells following DNA Damage1

Elizabeth A. Barnes, Lisa A. Porter, Jean-Luc Lenormand, Ryan W. Dellinger and Daniel J. Donoghue2

Department of Chemistry and Biochemistry, and Center for Molecular Genetics, University of California, San Diego, La Jolla, California 92093-0367 [E. A. B., L. A. P., D. J. D.]; Protein’eXpert, Inc., 38054 Grenoble Cedex, France [J-L. L.]; and NewBiotics, Inc., San Diego, California 92121 [R. W. D.]

Speedy (Spy1) is a novel cell cycle regulator that binds and activates cdk2, and was originally identified as a suppressor of Rad1 deficiency in Schizosaccharomyces pombe. Here we demonstrate that overexpression of human Spy1 enhances mammalian cell viability during cellular responses to DNA damage induced by genotoxic agents such as camptothecin, cisplatin, and hydroxyurea. Clonogenic survival assays and comet assays also show that Spy1 expression enhances cell survival after DNA damage. Consistent with Spy1 having a role in the DNA damage response, endogenous Spy1 protein levels are up-regulated in response to DNA damage induced by camptothecin, cisplatin, or hydroxyurea. We found that Spy1 can activate cdk2 during the DNA damage response and that expression of a dominant-negative form of cdk2 overrides Spy1 function in damaged cells. Lastly, ablation of endogenous Spy1 expression using small interference RNA results in hypersensitization of cells to DNA damage. Together, these results demonstrate that human Spy1 mediates protection of mammalian cells against DNA damage.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Al Sorkhy, R. Craig, B. Market, R. Ard, and L. A. Porter
The Cyclin-dependent Kinase Activator, Spy1A, Is Targeted for Degradation by the Ubiquitin Ligase NEDD4
J. Biol. Chem., January 30, 2009; 284(5): 2617 - 2627.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Golipour, D. Myers, T. Seagroves, D. Murphy, G. I. Evan, D. J. Donoghue, R. A. Moorehead, and L. A. Porter
The Spy1/RINGO Family Represents a Novel Mechanism Regulating Mammary Growth and Tumorigenesis
Cancer Res., May 15, 2008; 68(10): 3591 - 3600.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. F. Gastwirt, D. A. Slavin, C. W. McAndrew, and D. J. Donoghue
Spy1 Expression Prevents Normal Cellular Responses to DNA Damage: INHIBITION OF APOPTOSIS AND CHECKPOINT ACTIVATION
J. Biol. Chem., November 17, 2006; 281(46): 35425 - 35435.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.